It's called ibrutinib, and it's a potential breakthrough in treating chronic lymphocytic leukemia that could leave patients with fewer side effects than chemotherapy.
http://www.cnn.com/2013/06/20/health/time-leukemia-drug/index.html
http://www.cnn.com/2013/06/20/health/time-leukemia-drug/index.html
No comments:
Post a Comment